logo
May they get what they voted for: who is Dr. Christina Propst, the pediatrician who mocked Texas flood victims; claims they voted for Trump

May they get what they voted for: who is Dr. Christina Propst, the pediatrician who mocked Texas flood victims; claims they voted for Trump

Time of India16 hours ago
Dr. Christina B. Propst, a Houston-based pediatrician, was terminated from her position after a Facebook post she wrote about the deadly
Texas floods
sparked widespread outrage. In the now-deleted post,
Propst
appeared to link the tragedy, which claimed over 100 lives, including children, to the political leanings of
Kerr County
residents, many of whom voted for
Donald Trump
.
Her remarks were widely condemned as insensitive and politicizing a disaster that has left the state in mourning. The post, which circulated under her old Facebook username 'Chris Tina,' gained traction after it was amplified by the conservative account Libs of TikTok.
Also Read:
Japan, South Korea, Malaysia among 14 nations facing tariffs; what might get pricier for Americans
The backlash was swift, with her employer,
Blue Fish Pediatrics
, first suspending and then firing her, citing a failure to uphold compassion and professionalism. The controversy led to her dismissal and ignited a national debate over ethics, speech, and accountability in healthcare, while some netizens even demanded that her license be revoked.
Who is Dr. Christina B. Propst?
Live Events
Dr. Christina B. Propst is a Houston-based pediatrician. Known previously for her long-standing career in child healthcare, Dr. Propst had over two decades of experience in pediatrics and was affiliated with multiple medical institutions, including Blue Fish Pediatrics, Memorial Hermann Health System, and Houston Methodist.
She completed her medical degree at Tulane University School of Medicine in 1998 and went on to finish her pediatric residency at Baylor College of Medicine-affiliated hospitals the same year.
Over the last 25 years, she has built a reputation in Houston's medical community as a caring and competent pediatrician, serving thousands of children and families.
Also Read:
Who was Richard Dick Eastland? The Camp Mystic director dies trying to save girls in Texas floods
Why was Propst fired?
Dr. Propst's career ended abruptly after a post she made under the name 'Chris Tina' went viral. In it, she appeared to mock the victims of the deadly Texas floods in Kerr County, insinuating that the majority Republican-voting population had received 'what they voted for.'
The message, widely condemned as cruel and politicized, prompted massive backlash online and was amplified by conservative social media accounts.
'May all visitors, children, non-MAGA voters and pets be safe and dry,' Probst wrote in the now-viral post
'Kerr County MAGA voted to gut FEMA. They deny climate change. May they get what they voted for. Bless their hearts.'
Her employer, Blue Fish Pediatrics, first suspended her before ultimately terminating her employment, stating that her comments did not reflect the values of the practice.
Also Read:
NFL star, TV host, Clare's ex, who is Dale Moss and why is he back on Bachelor in Paradise?
The Memorial Hermann Health System also distanced itself from her, clarifying that she was not their employee and reiterating their zero-tolerance policy for divisive rhetoric.
Meanwhile, the
Texas Medical Board
acknowledged the controversy and said it would investigate any formal complaints, though no official inquiry has been announced.
Economic Times WhatsApp channel
)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

JNUSU president hospitalised amid ongoing hunger stir
JNUSU president hospitalised amid ongoing hunger stir

The Hindu

timean hour ago

  • The Hindu

JNUSU president hospitalised amid ongoing hunger stir

Jawaharlal Nehru University Students' Union (JNUSU) president Nitish Kumar was hospitalised on Tuesday, the 12th day of an ongoing hunger strike, after he complained of chest pain, JNUSU members said. Students have been on an indefinite hunger strike demanding the reinstatement of the Jawaharlal Nehru University Entrance Examination (JNUEE), which has been replaced with a UGC-NET-based entrance system in recent years. The other demands include increasing the merit-cum-means scholarship and revocation of hostel eviction notices for PhD scholars on academic extension. Mr. Kumar, a member of the Left-affiliated All India Students' Association (AISA), was taken to Safdarjung Hospital. Loni, a JNU student and an AISA activist, who participated in the hunger strike, was also rushed to AIIMS on Tuesday afternoon after she blacked out. Both of them are said to be in stable condition. The JNUSU, in an open letter to the JNU Teachers' Association, stated that 14 students have been on hunger strike. 'Our principal demand is the restoration of the JNUEE. This exam has long ensured that this campus remains accessible to students from diverse backgrounds across the country. Its continuation is essential for safeguarding the inclusive character and academic integrity of JNU,' the letter read.

Experts call for inclusion of Chronic Kidney Disease in national NCD programme
Experts call for inclusion of Chronic Kidney Disease in national NCD programme

The Hindu

timean hour ago

  • The Hindu

Experts call for inclusion of Chronic Kidney Disease in national NCD programme

Hyderabad-based dialysis care network, NephroPlus, has urged policymakers to include Chronic Kidney Disease (CKD) screening in India's flagship National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), as it released a white paper highlighting the rising burden of CKD across India and neighbouring countries. Speaking at a media briefing in Hyderabad on Tuesday, NephroPlus Group CEO Rohit Singh said the findings of the white paper and a large-scale screening initiative make a strong case for integrating CKD testing, particularly serum creatinine and urine albumin-to-creatinine ratio (ACR), into existing government-led screenings for hypertension and diabetes. 'The burden is silent but severe. CKD needs to be part of India's NCD strategy immediately,' he said. The paper is based on data from a kidney health screening campaign conducted in the lead-up to World Kidney Day in March. The campaign spanned 30 locations across India, the Philippines, and Uzbekistan, and covered 12 Indian States. A total of 10,501 persons pledged for kidney health awareness, of whom more than 5,000 underwent free serum creatinine and estimated glomerular filtration rate (eGFR) tests. NephroPlus found that several Indian States reported high prevalence of CKD risk factors. Jharkhand topped the list, followed by Haryana and Uttarakhand, Andhra Pradesh, Bihar, Delhi, Karnataka, Maharashtra, Uttar Pradesh, Telangana, Gujarat and Rajasthan. NephroPlus co-founder Kamal D. Shah stressed the economic and emotional toll of dialysis. 'Dialysis is not just a treatment; it is a lifelong ordeal that drains families physically, emotionally and financially. Our data shows that investing ₹1 in prevention saves ₹10 to ₹15 in future dialysis costs,' he said.

Pharma lobby flags 'cumbersome' export rule, seeks change
Pharma lobby flags 'cumbersome' export rule, seeks change

Time of India

time2 hours ago

  • Time of India

Pharma lobby flags 'cumbersome' export rule, seeks change

New Delhi: A significant dip in exports has prompted pharma lobby groups to raise a demand for changing the centralised no-object certification (NOC) provision for drug exports . The provision, which requires pharma companies to seek an approval from the national regulatory agency of the importing country or an NOC from the Indian regulator for shipments, has resulted in a drop in exports and diverted trade to other nations, industry executives told ET. The issue was raised in a meeting held on Monday at Niti Aayog . "Pharma exports have suffered due to the mismatch or an anomaly in newly introduced regulatory standards by the drug regulatory authority of India," said a person who attended the meeting. In early March, the Drugs Controller General of India (DCGI) updated the export NOC checklist in the wake of events such as the controversy over a Mumbai-based drugmaker allegedly exporting addictive opioid drugs to West African nations such as Ghana and Nigeria. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like What the Market May Be Getting Wrong About Nvidia Seeking Alpha Read More Undo However, the stringent norms have started hurting exports, industry insiders said. "Taking approvals from different regulatory bodies has only made the whole process cumbersome," the person cited above said. He noted that medicines are manufactured depending on the patient population construct. Live Events For example, Dolo and other paracetamol tablets are approved in India in strengths of 325mg, 500 mg and 650 mg while in Nigeria, it's approved for a strength of 1,000 mg. To manufacture and export that, Indian drugmakers now require an NOC from Nigerian authorities. The lobby groups have urged the government to review the provision as, according to them, this would divert trade to other nations with less stringent regulations. "Such a condition has imposed an undue burden on Indian exporters, potentially stifling innovation and hindering the export of unapproved/banned products especially for the MSME pharmaceutical sector, which is under tremendous strain with respect to compliance to domestic and international guidelines and trade barriers (tariffs & non-tariffs),' an industry expert said on condition of anonymity. The Niti Aayog had called pharma experts to undertake an analysis of the current state of the industry, to understand the challenges faced by drugmakers and initiatives taken by them to ensure production of safe and effective products. Nikkhil K Masurkar, chief executive of Entod Pharmaceuticals, said the official think tank's call for a quality overhaul is both "timely and necessary." "While India has made remarkable strides as a global pharma hub, maintaining consistent, internationally acceptable quality standards remains a key challenge, especially among MSME companies," he said. "The root of the problem often lies not in intent, but in outdated infrastructure, fragmented regulatory enforcement, and insufficient technical training," Masurkar said. "To produce world-class medicines, we must invest in continuous quality improvement, digitalise compliance systems, and empower our MSME sector with both financial and technical support."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store